Orion Oyj operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orion Oyj with three other
pharmaceutical manufacturers in Europe:
Virbac
of FRANCE
(2019
sales of 938.34 million Euros [US$1.10 billion]
of which 59%
was Companion Animals),
Almirall SA
of SPAIN
(855.34 million Euros [US$1.01 billion]
of which 63%
was Own Network (Spain)), and
Alkermes Plc
which is
based in IRELAND
(1.05 billion Euros [US$1.23 billion]
of which 100%
was Medicines).
Sales Analysis.
During the year ended December of 2019, sales at
Orion Oyj were 1.05 billion Euro (US$1.24 billion).
This
is
an
increase of 7.5%
versus 2018, when the company's sales were 977.50 million Euro.
Despite this increase, sales are still
below the level achieved in 2017, when Orion Oyj
reported sales of 1.08 billion Euro.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Orion Oyj had sales
of 1.02 billion Euro.